Akorn-Fresenius Fight Over Canceled Deal Is Argued in Court

(Bloomberg) -- Akorn Inc., still trying to salvage its multibillion-dollar sale to German drugmaker Fresenius SE, argued that a trial judge improperly rewrote state law and used “guesswork” in allo...